From: hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer
Genotype distribution, n (%) | Risk for malignancya | Risk for multiple malignanciesb | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Controlc | Single malignancy cases | Multiple malignancy cases | Crude OR (95% CI) | p-value | Adjusted ORd (95% CI) | p-value | Crude OR (95% CI) | p-value | Adjusted ORd (95% CI) | p-value | |
CC | 245 (41.5) | 308 (43.3) | 130 (52.2) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
CT | 272 (46.0) | 324 (45.6) | 100 (40.2) | 0.87 | 0.22 | 0.86 | 0.22 | 0.69 | 0.021 | 0.68 | 0.024 |
(0.70 - 1.08) | (0.68 - 1.09) | (0.51 - 0.95) | (0.548- 0.95) | ||||||||
TT | 74 (12.5) | 79 (11.1) | 19 (7.6) | 0.74 | 0.085 | 0.68 | 0.041 | 0.48 | 0.0065 | 0.46 | 0.0046 |
(0.53 - 1.04) | (0.48 - 0.98) | (0.27 - 0.82) | (0.25 - 0.79) | ||||||||
Dominant model | |||||||||||
CC | 245 (41.5) | 308 (43.3) | 130 (52.2) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
CT + TT | 346 (58.5) | 403 (56.7) | 119 (47.8) | 0.84 | 0.11 | 0.82 | 0.087 | 0.65 | 0.0043 | 0.63 | 0.0040 |
(0.69 - 1.04) | (0.66 - 1.03) | (0.48 - 0.87) | (0.45 - 0.86) | ||||||||
Recessive model | |||||||||||
CC + CT | 517 (87.5) | 632 (88.9) | 230 (92.4) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
TT | 74 (12.5) | 79 (11.1) | 19 (7.6) | 0.79 | 0.16 | 0.73 | 0.080 | 0.58 | 0.033 | 0.55 | 0.024 |
(0.58 - 1.10) | (0.53 - 1.04) | (0.33 - 0.96) | (0.31 - 0.93) | ||||||||
Additive model e | 0.86 | 0.063 | 0.70 | 0.036 | 0.69 | 0.0017 | 0.67 | 0.0014 | |||
(0.74 - 1.01) | (0.51 - 0.98) | (0.55 - 0.87) | (0.53 - 0.86) |